Case Report: Synaptophysin-positive SMARCA4-deficient undifferentiated thoracic tumour: a diagnostic pitfall with therapeutic implications

Chang-Sen Bai, Xiong-Wen He, Shu Lin, Bai-Cheng Xu, Qi-Xing Yan, Ming-Fa Wang, Yue-Can Zeng, Jing-Ru Luo, Wen-Jun Tang · 2026

Read Case Report: Synaptophysin-positive SMARCA4-deficient undifferentiated thoracic tumour: a diagnostic pitfall with therapeutic implications by Chang-Sen Bai, Xiong-Wen He, Shu Lin, Bai-Cheng Xu, Qi-Xing Yan, Ming-Fa Wang, Yue-Can Zeng, Jing-Ru Luo, Wen-Jun Tang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13278859.txt.

Description

Chang-Sen Bai and co-authors report a hard-to-classify chest tumour in a 2026 case study. A 43-year-old male smoker had a SMARCA4-deficient undifferentiated thoracic tumour, a rare and aggressive cancer with no standard treatment. One tissue marker, synaptophysin, was present, which usually points toward neuroendocrine tumours instead.

Other neuroendocrine markers were negative, and the growth marker showed very rapid cell division. The team read the lone marker as partial lineage leakage rather than true neuroendocrine identity. Combined platinum chemotherapy and immunotherapy shrank the metastatic cancer, and the partial response held beyond twelve months. The authors suggest this marker pattern may flag patients who benefit from that combination.

Catalog record

CREATORChang-Sen Bai, Xiong-Wen He, Shu Lin, Bai-Cheng Xu, Qi-Xing Yan, Ming-Fa Wang, Yue-Can Zeng, Jing-Ru Luo, Wen-Jun Tang
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE15 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13278859

Browse the full library · About the Tower of Babel